GGTI-2133
CAS: 1217480-14-2
Ref. 3D-SYB48014
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Información del producto
GGTI-2133 is a chemokine that has been shown to be a potent autophagy inducer. Autophagy is the process by which cells break down and recycle their own components in order to maintain homeostasis. GGTI-2133 has been shown to inhibit cholesterol synthesis, decrease lung damage, and induce bronchial dilation. The drug has also been shown to increase the production of geranylgeranylated proteins, which may have therapeutic potential for cancer treatment. A molecular modeling study of GGTI-2133 shows that it binds to the same binding site as statins on HMG-CoA reductase, an enzyme involved in cholesterol synthesis. This may lead to synergistic effects when taken with statins for the treatment of cardiovascular disease and diabetes mellitus type II.
Propiedades químicas
Consulta técnica sobre: 3D-SYB48014 GGTI-2133
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.